Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upjohn, J&J to pay P&G 7% of Motrin IB Sinus, Sine-Aid IB sales under jury decision.

This article was originally published in The Tan Sheet

Executive Summary

MCNEIL, UPJOHN ORDERED TO PAY RICH-VICKS 7% ROYALTIES on "infringing sales" of Motrin IB Sinus and Sine-Aid IB under a May 10 decision resolving a patent infringement suit filed by Procter & Gamble's Richardson-Vicks unit Dec. 1, 1993. The jury found that Rich-Vicks' patent for "cough-cold mixtures comprising nonsteroidal anti-inflammatory drugs" containing 200 mg ibuprofen and 30 mg pseudoephedrine is valid and enforceable, and decided that Rich-Vicks is entitled to "a reasonable royalty rate" of 7% of the infringing products' sales from Dec. 1, 1993 to the present.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel